Subacute thyroiditis is suspected to be a viral infectious disease, while Graves' disease is an auto-immune disease. Consequently, there appears to be no relation between the causes of the two diseases. However, we encountered 7 patients with Graves' disease following subacute thyroiditis. In the literature, 26 patients with Graves' disease following subacute thyroiditis have been reported (Sheets 1955; Perloff 1956; Werner 1979; Wartofsky and Shaaf 1987; Fukata et al. 1992 ; Bartalena et al. 1996; Bennedbeak et al. 1996; Grunenberger et al. 1998; Iitaka et al. 1998 Iitaka et al. , 2001 Wang and Renedo 2004) . The diagnosis of Graves' disease in such patients is always difficult because of atypical signs and symptoms and an unclear onset time.
In the present study, we describe 7 patients with subacute thyroiditis followed by Graves' disease. We also discuss on the possible mechanisms involved in the development of Graves' disease following subacute thyroiditis.
Methods
The serum levels of thyroxine (T 4 ) (normal range 6.3-12.4 μg/ dl) were measured using a Riabead kit (Dainabot Co. Ltd., Tokyo, Japan). Anti-thyroglobulin and anti-microsomal antibodies (TGHA, MCHA) (normal range < 100 for both) were determined by the passive particle agglutination technique (Serodia ATG and Serodia AMC, Fujirebio, Inc. Tokyo, Japan). The following hormone and antibody levels were determined by Elecsys kits (Roche Diagnostics GmbH, Penzberg, Germany). Normal ranges are indicated in parentheses: anti-thyroid-stimulating hormone (TSH) receptor antibody (TRAb) (< 10%), free triiodothyronine (fT 3 ) (2.3-4.0 pg/ml), TSH (0.50-4.60 μIU/ml), free T 4 (fT 4 ) (0.90-1.70 ng/dl), anti-thyroglobulin antibody (TgAb) (< 0.3 U/ml), and anti-thyroid peroxidase antibody (TPOAb) (< 0.3 U/ml). Thyroid stimulating antibody (TSAb) (< 210%) was measured as the percent increase in cAMP production using porcine thyroid cells with a TSAb assay kit (Yamasa Co., Choshi, Chiba, Japan). The diagnosis of subacute thyroiditis and Graves' disease was made following the diagnostic criteria of the Japanese Thyroid Association: tender goiter, high C-reactive protein (CRP) and/or the 1-hour erythrocyte sedimentation rate (ESR), high fF 4 and low TSH (less than 0.1 μU/ml) in subacute thyroiditis; and thyrotoxic symptoms (tachycardia, weight loss, finger tremor, hyperhidrosis, etc), diffuse goiter, high fT 4 , low TSH, positive TRAb and a high radioactive iodine uptake rate with a scintigram of a homogeneous thick silhouette in Graves' disease. The 24-hour thyroid radioiodine ( 131 I) uptake ratio (TU) was determined after a 1-week restriction of the patient's iodine-rich diet (normal range 10-35%). The frequency of the disease was calculated from the total number of Graves' disease and subacute thyroiditis cases seen between the times of patient 1 (1985) and of patient 7 (2008) in our clinic.
Clinical findings
A total of 25,267 thyroid disease patients made their first visits to our clinic in a period of 24 years between 1985 and 2008. Among them, Graves' disease accounted for 4,617 patients (18.2%), while subacute thyroiditis patients were 918 patients (3.6%). In Graves' disease, the male-tofemale ratio was 1:4.6, and their age range was 6~86 years (mean 40.6 years). The corresponding figures for subacute thyroiditis patients were 1:7.0 and 14~78 years (mean 48.7 years). We have encountered 7 patients (one male and six female) with subacute thyroiditis followed by Graves' disease in this period (Table 1) ; its incidence was 0.15% of the 4617 patients with Graves' disease and 0.76% of the 918 patients with subacute thyroiditis. The clinical features of the seven patients are summarized below.
Patient 1: 43-year-old man (Fig. 1 ). When the patient visited our clinic on Sept. 27, 1985, he complained of slight pain at the front and left of his neck and fever up to 39°C over the previous 2 weeks. The right thyroid lobe was swollen, hard, and tender. Ultrasonography (US) revealed a low-echoic area in the lobe, and the presence of subacute thyroiditis was identified using a fine needle aspiration biopsy. The serum T 4 concentration was high, and the ESR was highly accelerated. Subacute thyroiditis was diag-nosed, and 10 to 30 mg of prednisolone was administered per day. This normalized the high serum T 4 and the accelerated ESR, and so the prednisolone dosage was tapered. However, the serum T 4 increased again 3 months after the onset of the disease. Both TRAb and TU were high. Scintigraphy showed a homogeneous thick silhouette. These findings led to a diagnosis of Graves' disease, following the subacute thyroiditis. Prednisolone administration was therefore discontinued and methimazole (MMI) administration begun. Four months later, the patient became hypothyroid, and so levothyroxine (LT 4 ) treatment was added, and this combination was discontinued 3 months later. Since then, 23 years have now passed, and the thyroid is normal in size and euthyroid. The patient appears to be in prolonged or permanent remission.
Patient 2: 44-year-old woman (Fig. 2) . The patient complained of anterior neck pain, fever around 38°C, and cough that had persisted for 10 days. She presented at our clinic on July 20, 1992, with the right lobe of the thyroid swollen, hard and tender. US showed a localized, lowechoic area in both thyroid lobes, especially the right. Serum fT 4 was high, TSH was low, and the ESR was highly accelerated. A diagnosis of subacute thyroiditis was made, and a daily dose of 5-20 mg of prednisolone was given. The temperature returned to normal and the painful thyroid induration disappeared one month later. The ESR returned to normal simultaneously, but the serum fT 4 was still elevated 2 months after onset. TU was high, TRAb was positive, and the thyroid scintigram showed a thick, homogeneous silhouette. These findings led to the diagnosis of Graves' disease following the subacute thyroiditis. MMI administration was then initiated, and the patient became euthyroid 2 months later. However, hyperthyroidism recurred again and again, and so radio-iodine was administered from 5 years after the original onset, and the patient returned to a euthyroid condition. She did not return again after that to our clinic.
Patient 3: 49-year-old woman (Fig. 3 ). The patient presented at our clinic on Jan. 16, 1993, complaining of pain of a month's duration on the left of the front of her neck. The left thyroid lobe was swollen, hard and tender. US showed a low-echoic area in the same lobe. Her ESR was highly accelerated, and her serum fT 4 was a little high (and later increased further); thus, subacute thyroiditis was diagnosed. The pain was relieved by daily doses of 1.5 g of acetylsalicylic acid, but 6 months of administration was necessary to normalize the accelerated ESR. However, high serum fT 4 persisted even longer. TU and TRAb were high, and the thyroid scintigram showed a thick, homogeneous silhouette. This pointed to the diagnosis of Graves' disease following the subacute thyroiditis. Radio-iodine was given once, and then potassium iodide was administered temporarily. Almost 1.5 years later, levothyroxine replacement therapy became necessary because the patient became hypothyroid. Now, 15 years later, she is eumetabolic. Patient 4: 40-year-old woman ( Fig. 4 ). She complained of anterior throat pain for 2 days, and then consulted a local physician on Oct. 9, 1992. A painful induration was noted in the right thyroid lobe. Her ESR was greatly accelerated, and her serum fT 4 was high. Subacute thyroiditis was diagnosed, prednisolone 5-15 mg/day was given for 3.5 months and the induration and pain disappeared after 1 month. However, the drug was discontinued temporarily because the patient complained of abdominal pain, which seemed to be a side effect of the drug. After 20 days without prednisolone, she suffered a painful induration in the left thyroid lobe, and so the prednisolone treatment was started again. The painful induration disappeared 10 days later, and the drug dosage was tapered. At that time, which was 6 months after the onset, she complained of tremor in both hands, and the serum fT 4 was very high, so she was transferred to our clinic. A diffuse goiter about 30 ml in volume was noted, and while the TRAb was very high, the ESR was normal. Following the subacute thyroiditis, therefore, Graves' disease was diagnosed. MMI was administered, and was later combined with LT 4 . Both were discontinued 4 years later. Now, 14 years later, the patient is still in remission.
Patient 5: 31-year-old woman (Fig. 5 ). The patient complained of mild pain in the right anterior aspect of the neck on Aug. 17, 1994, and visited a local physician, who identified a painful induration in the thyroid. Subacute thyroiditis was diagnosed. She was treated with prednisolone for 20 days and then transferred to our clinic. The thyroid was slightly enlarged, being 20 ml in volume, but the painful induration had already disappeared. However, an irregular low-echoic area remained in the left thyroid lobe. It was diagnosed as incompletely healed subacute thyroiditis, and so prednisolone was administered continuously at 10-30 mg/day, and the condition disappeared about 50 days later. However, TRAb was positive at that time, which was a concern. Nine years later, when the patient was 40 years of age, her right thyroid lobe was again swollen, hard and tender. US revealed a low-echoic area in that lobe. ESR was greatly accelerated, and the serum fT 4 was high, and TSH, low. Second subacute thyroiditis was diagnosed, so 5-20 mg/day of prednisolone was administered. Five months later, no signs or symptoms remained. Since all the examination data were within normal limits, prednisolone administration was discontinued. However, a month later, which was 6 months from the onset of the second bout of subacute thyroiditis, the patient complained of palpitation, fatigue, tremor and hot flushes. She had high serum fT 4 , low TSH, and normal ESR. TRAb and TSAb were both high, and the thyroid was diffusely enlarged to a volume of about 20 ml. The TU was also elevated. The thyroid scintigram showed a large, homogeneous, thick silhouette.
These findings pointed to the diagnosis of Graves' disease, following the second subacute thyroiditis. The Graves' disease was treated with radio-iodine, which led to a hypothyroid condition, and so LT 4 replacement was performed. Patient 6: 59-year-old woman (Fig. 6 ). Having fever of 38°C and painful thyroid swelling, she consulted a local physician on Feb. 2, 2007. On examination, the ESR was highly accelerated, leading to the diagnosis of subacute thyroiditis. A course of prednisolone 5-20 mg/day quickly relieved the symptoms, but the patient's condition became aggravated again 11 days later, resulting in her transfer to our clinic. A diffuse goiter, enlarged to a volume of about 30 ml was found, the right thyroid lobe was swollen hard and very tender, and showed a localized low-echoic area. The serum fT 4 was slightly raised and the TSH was low. The ESR was greatly accelerated. TGAb was slightly positive. Accordingly, a diagnosis of relapsed subacute thyroiditis was made, and the prednisolone dosage was increased to 20 mg. The fever decreased and the pain abated. The high serum fT 4 returned to the normal range. At this time, TRAb and TSAb were tested to rule out Graves' disease, but unexpectedly, they were positive, which was somewhat puzzling. Five months after the onset of subacute thyroiditis, the thyroid induration and the low echoic area disappeared, the ESR was normalized, and the prednisolone administration was discontinued. However, subacute thyroiditis appeared again 2 weeks later. The patient had 38°C fever and an accelerated ESR. The serum fT 4 was high. The fever was reduced and the ESR was normalized by readministration of prednisolone at 20-25 mg/day. Meanwhile, the high serum fT 4 persisted for 2.5 months, until 8 months after the onset of the disease. TRAb was extremely high, and the TU was high. The thyroid 131 I scintigram showed a thick homogeneous silhouette. Graves' disease following the subacute thyroiditis was diagnosed. Radio-iodine administration led to a hypothyroid condition, which was normalized by LT 4 replacement.
Patient 7: 66-year-old woman (Fig. 7) . Suffering from anterior neck pain and fever on Feb. 14, 2008, the patient visited a local physician. The right lobe of the thyroid was very tender, and the ESR was markedly accelerated. The serum fT 4 was slightly raised. The physician's diagnosis was subacute thyroiditis. Meanwhile, TRAb was unexpectedly high, so that the physician was at a loss. Prednisolone 15 mg/day was administered and the symptoms improved sharply 10 days later. However, she wished to be treated by a specialist and was transferred to our clinic, at which time her thyroid was swollen to about 20 ml and a painful induration could be felt in the right thyroid lobe, where a localized low-echoic area could be seen. The ESR was accelerated. The serum fT 4 was high, and prednisolone 15 mg/day administration was continued. On March 6, the painful induration disappeared, and the fever had subsided. However, the serum fT 4 was still high, and TRAb and TSAb were revealed to be very high. A thyroid scintigram showed a homogenous thick silhouette. Graves' disease following subacute thyroiditis was diagnosed. Radio-iodine was given. Potassium iodide was combined with it, but was discontinued on Apr. 24 because the patient's condition became euthyroid.
The laboratory data, treatment and outcomes for these seven patients are summarized in Table 1 . These patients comprised one man and six women, with an age range of 31~66 years (mean, 48.7 years). Patient 5 contracted subacute thyroiditis twice, but Graves' disease followed the second occurrence. The intervals between the onset of subacute thyroiditis and Graves' disease ranged from 1 to 8 months (mean, 4.7 months). In all patients, the Graves' dis-ease became euthyroid, fell into remission or became eumetabolic as a result of thiamazole or radio-iodine therapy.
Discussion
The association of Graves' disease and subacute thyroiditis is very rare. In fact, we encountered only 7 patients during a period of 24 years in our thyroid clinic. All of our seven patients initially had subacute thyroiditis, and then suffered from Graves' disease. In addition, these two diseases occurred in an almost continuous sequence. Therefore, most patients showed mixed signs and symptoms of both diseases in the switchover period. The diagnosis of Graves' disease is always difficult because of the presence of atypical signs and symptoms and the unpredictable and unclear onset time. Patient 5 suffered twice from subacute thyroiditis. It is unlikely that the first bout of subacute thyroiditis could have played a part in the onset of Graves' disease because of the long 8-year interval. Subacute thyroiditis is probably a viral inflammatory disorder, while Graves' disease is an autoimmune disease. Thus, the association of these two diseases may be accidental. However, if these 7 patients' conditions are considered together, it is reasonable to suspect that subacute thyroiditis damages the thyroid, which in turn leads to the immunological activation of the latent Graves' disease. Volpé (1978) found thyroid auto-antibodies in some subacute thyroiditis patients. Generally, the presence of these antibodies is transitory and they disappear several months later. He considered that this autoimmune phenomenon was secondary to the release of antigenic material from the thyroid and was almost certainly not related to the pathogenesis of this disease. Iitaka et al. (1998) reported that TSH receptor antibody-associated thyroid dysfunction can develop in some patients following subacute thyroiditis, but is usually transient. The findings with our seven patients demonstrated that Graves' disease is sometimes activated by a prior bout of subacute thyroiditis and is sometimes transitory.
In the literature, 26 patients with Graves' disease preceded by subacute thyroiditis were the subjects of reports by a total of 10 authors (Table 2) . These patients comprised 13 women, 3 men and 10 patients of unknown sex. Most were middle-aged. The intervals between the onset of subacute thyroiditis and the period of switchover to Graves' disease ranged from 38 days to 18 months. Radioactiveiodine uptake values in the subacute thyroiditis periods were almost all low and those during the bouts of Graves' disease were high. Sheets (1955) dealt with a patient whose condition was the most typical in interval time and in change of radioactive iodine values. Four patients with TU above 10% in the subacute thyroiditis period are recorded in Table 2 . These findings seemed curious because TU is usually low at the onset of the disease. However, it is conceivable that, after 3 weeks to 2 months had elapsed, the patients may have already begun their convalescence. They were all negative for most of the thyroid-directed autoantibodies in the subacute thyroiditis period, but positive in the Graves' disease phase. In Perloff's first and second patients (1956), the thyroids were extirpated as treatment for the Graves' disease. There were mixed histological findings of Graves' disease and subacute thyroiditis. The third patient had exophthalmos, and the fourth showed lid retraction and staring expression. In Werner's patient (1979) , there was bilateral upper lid fullness. Wartofsky and Shaaf's first patient (1987) had Graves' disease that went into remission after PTU administration, but then relapsed after a bout of subacute thyroiditis. Fukata et al. (1992) dealt with two patients, in whom Graves' disease developed 7 and 8 years after the onset of subacute thyroiditis. As mentioned in relation to our patient 5, it is unlikely that the bout of subacute thyroiditis that preceded it could have played a part in the onset of Graves' disease because of the 7-to-8 year interval. Bartalena et al. (1996) reviewed 11 patients and included one of his own in his report. Bennedbeak et al. (1996) reported a patient whose subacute thyroiditis relapsed after discontinuation of prednisolone administration, and Graves' disease occurred simultaneously, as in our patients 4 and 6. The Graves' disease in the patient of Grunenberger et al. (1998) slightly resembles that in Wartofsky and Shaaf's first patient (1987), because it went into remission after MMI administration and then relapsed. The radioactive iodine uptake of the left thyroid lobe was high, and the histological findings of the resected left lobe showed evidence of treated Graves' disease. In the right lobe, there were signs of subacute thyroiditis, namely, scat-tered giant cells and fibrosis. Iitaka et al. (1998 Iitaka et al. ( , 2001 reported hyperthyroidism in 11 patients after subacute thyroiditis was seen in 1697 patients. Nine of them were treated with anti-thyroid drugs. In one patient, the condition was resolved spontaneously within 8 months, and in two of them, ophthalmopathy similar to that of Graves' disease was present. In Wang and Renedo's patient (2004) the subacute thyroiditis was accompanied with mild primary hyperparathyroidism. In the patient of Pichler et al. (2002) , however, the onsets of the diseases occurred in the reverse order. This patient's Graves' disease went into remission for 30 years after thiamazole administration and then subacute thyroiditis manifested. Subacute thyroiditis was healed by administering an antipyretic, but the patient remained hypothyroid. Iitaka et al. (1998) reported subacute thyroiditis in a woman who was treated with prednisolone, after which her serum thyroid hormone level was decreased. However, this level was increased again 3 months later with elevated TU of 66%. She was treated with MMI for 11 months. Eleven years after the first episode of subacute thyroiditis, she experienced a second episode, but interestingly, hyperthyroidism did not recur after the second episode.
Two patients with silent thyroiditis (painless thyroiditis or transient thyrotoxicosis) associated with Graves' disease were seen in our clinic. One patient was a 55-year-old woman with Graves' disease who was in remission after being prescribed MMI. She developed painless thyroiditis twice, and the Graves' disease relapsed after the second episode. The other patient was a 70-year-old woman who developed Graves' disease after painless thyroiditis. Silent thyroiditis and Graves' disease are two clinical entities belonging to the wide spectrum of autoimmune thyroid diseases. The two diseases are closely linked because of the development of Graves' disease followed by silent thyroiditis or the reverse. The pathogenetic basis of silent thyroiditis following Graves' disease is unknown. However, the mechanism of development of Graves' disease after the presence of silent thyroiditis may be similar to that of Graves' disease after subacute thyroiditis.
In conclusion, the development of Graves' disease following subacute thyroiditis is a rare event. However, if a high serum concentration of thyroid hormone persists in the course of subacute thyroiditis, Graves' disease should be suspected.
